Overview

Degarelix Neo-Adjuvant Radical Prostatectomy Trial

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
To assess the effect of neo-adjuvant GnRH antagonist, degarelix, versus LHRH agonist on intratumoral levels of androgens.
Phase:
Phase 2
Details
Lead Sponsor:
University Health Network, Toronto
Treatments:
Bicalutamide